SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 101 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $65,442 | +2671.8% | 7,690 | +3229.0% | 0.00% | – |
Q1 2024 | $2,361 | -93.9% | 231 | -96.7% | 0.00% | – |
Q4 2023 | $38,716 | -71.3% | 7,065 | -80.2% | 0.00% | -100.0% |
Q3 2023 | $134,742 | +111.6% | 35,646 | +275.1% | 0.00% | +100.0% |
Q2 2023 | $63,670 | +99384.4% | 9,503 | -2.0% | 0.00% | 0.0% |
Q1 2023 | $64 | -8.6% | 9,701 | +18.9% | 0.00% | -33.3% |
Q4 2022 | $70 | -99.8% | 8,162 | +23.3% | 0.00% | +200.0% |
Q3 2022 | $35,000 | -22.2% | 6,620 | -37.3% | 0.00% | 0.0% |
Q2 2022 | $45,000 | -35.7% | 10,559 | -46.7% | 0.00% | 0.0% |
Q1 2022 | $70,000 | +268.4% | 19,803 | +608.8% | 0.00% | – |
Q4 2021 | $19,000 | -58.7% | 2,794 | -38.9% | 0.00% | -100.0% |
Q3 2021 | $46,000 | +35.3% | 4,574 | +317.3% | 0.00% | 0.0% |
Q2 2021 | $34,000 | +17.2% | 1,096 | +66.8% | 0.00% | – |
Q1 2021 | $29,000 | – | 657 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |